A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions

Abroad (travel likely)Unknown

Conditions

Atopic Dermatitis · Dermatology · Vitiligo · Alopecia Areata · Hidradenitis Suppurativa · Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

OM1, Boston, Massachusetts, United States

Study leads

Stefan Weiss, MD
Principal Investigator
OM1, Inc.

View source on ClinicalTrials.gov

No study contact email or phone is listed for this trial.

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Autoimmune Diseases · Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA)

Abroad (travel likely)RecruitingPHASE1

Charlestown, Australia · Birtinya, Australia

Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis

Atopic Dermatitis · Psoriasis · Healthy

Abroad (travel likely)Recruiting

Kiel, Germany

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

Abroad (travel likely)Recruiting

Bethesda, United States

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Irvine, United States · New York, United States